Well summarised, Bedger.
Even at its most basic level, the board now has some serious heavyweights on it and any negotiations with US pharma around Remplir distribution will met with some stout financial dralings around royalties and revenue.
They've strengthened the board for this explicit situation as well as laying the ground work for future distribution into Asia and the subcontinent.
This company could also do with a lot more liquidity and more eyes on it, which hopefully the addition of KB will bring.
- Forums
- ASX - By Stock
- Ann: The Hon Kim Beazley AC Joins Orthocell Board
Well summarised, Bedger. Even at its most basic level, the board...
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
40.0¢ |
Change
0.010(2.56%) |
Mkt cap ! $83.83M |
Open | High | Low | Value | Volume |
39.0¢ | 40.0¢ | 39.0¢ | $199.1K | 504.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3807 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 3666 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2599 | 0.385 |
3 | 27634 | 0.380 |
2 | 42700 | 0.375 |
4 | 23903 | 0.370 |
5 | 42071 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 3666 | 2 |
0.405 | 74300 | 2 |
0.410 | 45237 | 4 |
0.420 | 135239 | 3 |
0.425 | 39350 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |